{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:24:15Z","timestamp":1790771055115,"version":"4.1.0"},"reference-count":28,"publisher":"Radcliffe Medical Media Ltd","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"abstract":"<jats:p>Radiofrequency catheter ablation (CA) has an established role in the management of patients with structural heart disease presenting with recurrent ventricular tachycardia (VT). Due to the complex underlying substrate, high burden of comorbidities and concomitant heart failure (HF) status, these patients may be at higher risk of periprocedural complications. The prolonged low-output state related to VT induction and mapping, as well as the fluid overload due to irrigated CA and the use of general anaesthesia, may decompensate the HF status, leading to multiple-organ failure and increase in early post-procedural mortality. Proper identification of patients at high risk of periprocedural acute haemodynamic decompensation (AHD) has important implications in terms of procedural planning (i.e. prophylactic use of mechanical assistance devices) and pre-procedural management in order to optimise the HF status. In the present manuscript we focus on the clinical predictors of AHD and the strategies to improve pre-procedural risk stratification, as well as the evidence supporting the use of haemodynamic support during CA procedures.<\/jats:p>","DOI":"10.15420\/aer.2018.36.3","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T09:03:56Z","timestamp":1539075836000},"page":"1","source":"Crossref","is-referenced-by-count":65,"title":["Identifying Risk and Management of Acute Haemodynamic Decompensation During Catheter Ablation of Ventricular Tachycardia"],"prefix":"10.15420","volume":"7","author":[{"given":"Daniele","family":"Muser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon A","family":"Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson J","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Santangeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Cardiac Electrophysiology, Cardiovascular Division, Hospital of the University of Pennsylvania, USA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Cardiac Electrophysiology, Cardiovascular Division, Hospital of the University of Pennsylvania, USA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Cardiac Electrophysiology, Cardiovascular Division, Hospital of the University of Pennsylvania, USA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Cardiac Electrophysiology, Cardiovascular Division, Hospital of the University of Pennsylvania, USA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6096","reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ccep.2016.10.012","article-title":"Ventricular tachycardia ablation clinical trials","volume":"9","author":"Liang","year":"2017","unstructured":"1. Liang JJ, Muser D, Santangeli P. Ventricular tachycardia ablation clinical trials. Card Electrophysiol Clin 2017;9:153-65.","journal-title":"Card Electrophysiol Clin"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.hrthm.2016.03.004","article-title":"Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: a systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Santangeli","year":"2016","unstructured":"2. Santangeli P, Muser D, Maeda S, et al. Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: a systematic review and meta-analysis of randomized controlled trials. Heart Rhythm 2016;13:1552-9.","journal-title":"Heart Rhythm"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.15420\/aer.2015.4.3.177","article-title":"Long-term outcomes of ventricular tachycardia ablation in different types of structural heart disease","volume":"4","author":"Liang","year":"2015","unstructured":"3. Liang JJ, Santangeli P, Callans DJ. Long-term outcomes of ventricular tachycardia ablation in different types of structural heart disease. Arrhythm Electrophysiol Rev. 2015;4:177-83.","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1513614","article-title":"Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs","volume":"375","author":"Sapp","year":"2016","unstructured":"4. Sapp JL, Wells GA, Parkash R, et al. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med 2016;375:111-21.","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1161\/CIRCULATIONAHA.106.642892","article-title":"Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial","volume":"114","author":"Saxon","year":"2006","unstructured":"5. Saxon LA, Bristow MR, Boehmer J et al. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial. Circulation 2006;114:2766-72.","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1161\/CIRCEP.114.002155","article-title":"Acute hemodynamic decompensation during catheter ablation of scar-related ventricular tachycardia: incidence, predictors, and impact on mortality","volume":"8","author":"Santangeli","year":"2015","unstructured":"6. Santangeli P, Muser D, Zado ES, et al. Acute hemodynamic decompensation during catheter ablation of scar-related ventricular tachycardia: incidence, predictors, and impact on mortality. Circ Arrhythm Electrophysiol 2015;8:68-75.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1016\/j.jacc.2017.02.044","article-title":"Early mortality after catheter ablation of ventricular tachycardia in patients with structural heart disease","volume":"69","author":"Santangeli","year":"2017","unstructured":"7. Santangeli P, Frankel DS, Tung R, et al. Early mortality after catheter ablation of ventricular tachycardia in patients with structural heart disease. J Am Coll Cardiol 2017;69:2105-15.","journal-title":"J Am Coll Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1111\/pace.13149","article-title":"Impact of timing of recurrence following catheter ablation of scar-related ventricular tachycardia on subsequent mortality","volume":"40","author":"Muser","year":"2017","unstructured":"8. Muser D, Mendelson T, Fahed J, et al. Impact of timing of recurrence following catheter ablation of scar-related ventricular tachycardia on subsequent mortality. Pacing Clin Electrophysiol PACE 2017;40:1010-16.","journal-title":"Pacing Clin Electrophysiol PACE"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Muser D, Santangeli P, Castro SA, et al. Long-term outcome after catheter ablation of ventricular tachycardia in patients with nonischemic dilated cardiomyopathy. Circ Arrhythm Electrophysiol 2016;9:e004328.","DOI":"10.1161\/CIRCEP.116.004328"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10840-016-0168-8","article-title":"Outcomes of pre-emptive and rescue use of percutaneous left ventricular assist device in patients with structural heart disease undergoing catheter ablation of ventricular tachycardia","volume":"48","author":"Mathuria","year":"2017","unstructured":"10. Mathuria N, Wu G, Rojas-Delgado F, et al. Outcomes of pre-emptive and rescue use of percutaneous left ventricular assist device in patients with structural heart disease undergoing catheter ablation of ventricular tachycardia. J Interv Card Electrophysiol Int J Arrhythm Pacing 2017;48:27-34.","journal-title":"J Interv Card Electrophysiol Int J Arrhythm Pacing"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.15420\/aer.2014.3.3.161","article-title":"Ventricular tachycardia ablation - the right approach for the right patient","volume":"3","author":"Sadek","year":"2014","unstructured":"11. Sadek MM, Schaller RD, Supple GE, et al. Ventricular tachycardia ablation - the right approach for the right patient. Arrhythm Electrophysiol Rev 2014;3:161-7.","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1016\/j.jacc.2017.01.047","article-title":"Management of ventricular arrhythmias in patients with advanced heart failure","volume":"69","author":"Santangeli","year":"2017","unstructured":"12. Santangeli P, Rame JE, Birati EY, Marchlinski FE. Management of ventricular arrhythmias in patients with advanced heart failure. J Am Coll Cardiol 2017;69:1842-60.","journal-title":"J Am Coll Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1161\/CIRCEP.112.975888","article-title":"5 during scar-related ventricular tachycardia ablation (PERMIT 1)","volume":"6","author":"Miller","year":"2013","unstructured":"13. Miller MA, Dukkipati SR, Chinitz JS, et al. Percutaneous hemodynamic support with Impella 2.5 during scar-related ventricular tachycardia ablation (PERMIT 1). Circ Arrhythm Electrophysiol 2013;6:151-9.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.jacc.2011.06.022","article-title":"Activation and entrainment mapping of hemodynamically unstable ventricular tachycardia using a percutaneous left ventricular assist device","volume":"58","author":"Miller","year":"2011","unstructured":"14. Miller MA, Dukkipati SR, Mittnacht AJ, et al. Activation and entrainment mapping of hemodynamically unstable ventricular tachycardia using a percutaneous left ventricular assist device. J Am Coll Cardiol 2011;58:1363-71.","journal-title":"J Am Coll Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.15420\/aer.2015.4.1.19","article-title":"Contemporary mapping techniques of complex cardiac arrhythmias - identifying and modifying the arrhythmogenic substrate","volume":"4","author":"Koutalas","year":"2015","unstructured":"15. Koutalas E, Rolf S, Dinov B, et al. Contemporary mapping techniques of complex cardiac arrhythmias - identifying and modifying the arrhythmogenic substrate. Arrhythm Electrophysiol Rev. 2015;4:19-27.","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1161\/CIRCEP.113.000548","article-title":"Percutaneous left ventricular assist devices in ventricular tachycardia ablation: multicenter experience","volume":"7","author":"Reddy","year":"2014","unstructured":"16. Reddy YM, Chinitz L, Mansour M, et al. Percutaneous left ventricular assist devices in ventricular tachycardia ablation: multicenter experience. Circ Arrhythm Electrophysiol 2014;7: 244-50.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.hrthm.2014.04.018","article-title":"Procedural and clinical outcomes after catheter ablation of unstable ventricular tachycardia supported by a percutaneous left ventricular assist device","volume":"11","author":"Aryana","year":"2014","unstructured":"17. Aryana A, Gearoid O'Neill P, Gregory D, et al. Procedural and clinical outcomes after catheter ablation of unstable ventricular tachycardia supported by a percutaneous left ventricular assist device. Heart Rhythm 2014;11:1122-30.","journal-title":"Heart Rhythm"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Kusa S, Miller MA, Whang W, et al. Outcomes of ventricular tachycardia ablation using percutaneous left ventricular assist devices. Circ Arrhythm Electrophysiol 2017;10:pii:e004717.","DOI":"10.1161\/CIRCEP.116.004717"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.hrthm.2017.09.005","article-title":"Outcomes of rescue cardiopulmonary support for periprocedural acute hemodynamic decompensation in patients undergoing catheter ablation of electrical storm","volume":"15","author":"Enriquez","year":"2018","unstructured":"19. Enriquez A, Liang J, Gentile J, et al. Outcomes of rescue cardiopulmonary support for periprocedural acute hemodynamic decompensation in patients undergoing catheter ablation of electrical storm. Heart Rhythm 2018; 15:75-80.","journal-title":"Heart Rhythm"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Muser D, Liang JJ, Castro SA, et al. Outcomes with prophylactic use of percutaneous left ventricular assist devices in high-risk patients undergoing catheter ablation of scar-related VT: a propensity-matched analysis. Heart Rhythm 2018.","DOI":"10.1016\/j.hrthm.2018.04.028"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"184","DOI":"10.15420\/aer.2015.4.3.184","article-title":"Selecting the appropriate ablation strategy: the role of endocardial and\/or epicardial access","volume":"4","author":"Njeim","year":"2015","unstructured":"21. Njeim M, Bogun F. Selecting the appropriate ablation strategy: the role of endocardial and\/or epicardial access. Arrhythm Electrophysiol Rev 2015;4:184-8.","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1161\/CIRCULATIONAHA.110.945055","article-title":"Novel percutaneous cardiac assist devices: the science of and indications for hemodynamic support","volume":"123","author":"Naidu","year":"2011","unstructured":"22. Naidu SS. Novel percutaneous cardiac assist devices: the science of and indications for hemodynamic support. Circulation 2011;123:533-43.","journal-title":"Circulation"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00059-009-3289-3","article-title":"Percutaneous cardiopulmonary support for catheter ablation of unstable ventricular arrhythmias in high-risk patients","volume":"34","author":"Carbucicchio","year":"2009","unstructured":"23. Carbucicchio C, Bella PD, Fassini G, et al. Percutaneous cardiopulmonary support for catheter ablation of unstable ventricular arrhythmias in high-risk patients. Herz 2009;34:545-52.","journal-title":"Herz"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/S0003-4975(99)00543-3","article-title":"Cardiopulmonary support and extracorporeal membrane oxygenation for cardiac assist","volume":"68","author":"von Segesser","year":"1999","unstructured":"24. von Segesser LK. Cardiopulmonary support and extracorporeal membrane oxygenation for cardiac assist. Ann Thorac Surg 1999;68:672-7.","journal-title":"Ann Thorac Surg"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Baratto F, Pappalardo F, Oloriz T, et al. Extracorporeal membrane oxygenation for hemodynamic support of ventricular tachycardia ablation. Circ Arrhythm Electrophysiol 2016;9:pii:e004492.","DOI":"10.1161\/CIRCEP.116.004492"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1540-8167.2009.01673.x","article-title":"Use of the Impella microaxial blood pump for ablation of hemodynamically unstable ventricular tachycardia","volume":"21","author":"Abuissa","year":"2010","unstructured":"26. Abuissa H, Roshan J, Lim B, Asirvatham SJ. Use of the Impella microaxial blood pump for ablation of hemodynamically unstable ventricular tachycardia. J Cardiovasc Electrophysiol 2010;21:458-61.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1016\/j.ijcard.2013.06.035","article-title":"Catheter ablation of hemodynamically unstable ventricular tachycardia with mechanical circulatory support","volume":"168","author":"L\u00fc","year":"2013","unstructured":"27. L\u00fc F, Eckman PM, Liao KK, et al. Catheter ablation of hemodynamically unstable ventricular tachycardia with mechanical circulatory support. Int J Cardiol 2013;168:3859-65.","journal-title":"Int J Cardiol"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28. Aryana A, d'Avila A, Cool CL, et al. Outcomes of catheter ablation of ventricular tachycardia with mechanical hemodynamic support: an analysis of the Medicare database. J Cardiovasc Electrophysiol 2017;28:1295-302;","DOI":"10.1111\/jce.13312"}],"container-title":["Arrhythmia &amp; Electrophysiology Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aerjournal.com\/articles\/identifying-risk-and-management-acute-haemodynamic-decompensation-during-catheter-ablation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T10:47:17Z","timestamp":1596624437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerjournal.com\/articles\/identifying-risk-and-management-acute-haemodynamic-decompensation-during-catheter-ablation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"alternative-id":["aer.2018.36.3"],"URL":"https:\/\/doi.org\/10.15420\/aer.2018.36.3","relation":{},"ISSN":["2050-3377"],"issn-type":[{"value":"2050-3377","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}